TriSalus Life Sciences's total assets for Q3 2024 were $27.48M, a decrease of -15.28% from the previous quarter. TLSI total liabilities were $47.91M for the fiscal quarter, a -15.32% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.